Novo Nordisk's financial strength is evident through its 74% historical average ROIC and 85% gross margin. See why I rate NVO ...

Variant Bio, a small biotech company based in Seattle, is using genetic information from Indigenous people to develop drugs ...

However, when the sample was expanded to include those who ... eagerly awaited in the pharmaceutical industry this year. Novo Nordisk had been banking on the success of CagriSema to maintain ...

New research from University of Iowa dispels the belief that pharmaceutical mergers lead to higher drug prices, showing a decrease in prices for generic drugs.

Variant Bio, a small biotech company based in Seattle, is using genetic information from Indigenous people to develop ...

Analyst recommends Novartis as a Buy for long-term investors, BioAge a Hold, following strategic partnership for age-related ...

UK Biobank has today announced the launch of the world’s most comprehensive study of the proteins circulating in our bodies, which will transform the study of diseases and their treatments.

Global spread of powdery mildew threatens blueberries, costing millions and prompting better disease management strategies.

The brand-name versions, from drugmaker Novo Nordisk, sell for around $1,000 ... after the raid revealed that one of the samples sold by Arnold was nothing more than water, which could be ...

Research on fungus spread could help growers predict, monitor and control powdery mildew disease affecting blueberries.

Surgeons are collaborating with obesity medicine physicians, turning to GLP-1s to help high BMI patients qualify for surgery.